Gallagher Fiduciary Advisors’s Neogen NEOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$217K Sell
23,370
-1,200
-5% -$11.8K 0.01% 314
2025
Q4
$172K Buy
24,570
+2,451
+11% +$15.4K 0.01% 320
2025
Q3
$126K Sell
22,119
-618
-3% -$3.3K ﹤0.01% 303
2025
Q2
$109K Buy
22,737
+3,867
+20% +$22.2K ﹤0.01% 316
2025
Q1
$164K Buy
18,870
+3,155
+20% +$33.1K 0.01% 295
2024
Q4
$191K Buy
15,715
+597
+4% +$8.35K 0.04% 282
2024
Q3
$254K Buy
15,118
+3,669
+32% +$60.4K 0.05% 220
2024
Q2
$179K Buy
+11,449
New +$159K 0.04% 244

Other funds holding NEOG

Gallagher Fiduciary Advisors's NEOG Position: Q1 2026 in Review

Gallagher Fiduciary Advisors reduced its Neogen (NEOG) stake by 4.9% in Q1 2026, selling an estimated $11.8K and leaving 23,370 shares worth $217K. The position accounts for 0.01% of the portfolio, ranked #314.

Gallagher Fiduciary Advisors first reported a position in NEOG in Q2 2024 and has held it in 8 quarters since. The position peaked at $254K in Q3 2024. 307 funds tracked by Wall St. Rank hold NEOG as of Q1 2026.

  • Gallagher Fiduciary Advisors held 23,370 shares of Neogen worth $217K as of Q1 2026.
  • Gallagher Fiduciary Advisors sold 1,200 Neogen shares in Q1 2026, an estimated $11.8K.
  • Neogen made up 0.01% of Gallagher Fiduciary Advisors's portfolio in Q1 2026, its #314 holding.
  • Gallagher Fiduciary Advisors first reported a position in Neogen in Q2 2024 and has held it in 8 quarters since.
  • Gallagher Fiduciary Advisors's Neogen position peaked at $254K in Q3 2024.
  • 307 funds tracked by Wall St. Rank held Neogen as of Q1 2026.

Based on Gallagher Fiduciary Advisors's 13F filing for Q1 2026, filed 15 May 2026.